Dingdang Health Technology Group Ltd. repurchased 22,000 ordinary shares on 28 August 2026 via on-market transactions at HKD 0.83 per share, for a total consideration of HKD 18,260.
Following the transaction, issued shares outstanding (excluding treasury stock) declined marginally by 0.0018 % to 1.23916 billion. Treasury shares rose to 1.15 million, while total issued shares remained unchanged at 1.24031 billion.
The buyback forms part of the mandate approved on 23 June 2026, which authorises the company to repurchase up to 124.32 million shares. Including the latest purchase, Dingdang Health has repurchased 4.01 million shares under this mandate, equivalent to approximately 0.32 % of the share capital outstanding on the mandate date.
All repurchased shares have been retained as treasury shares; none have been cancelled. In line with Hong Kong Stock Exchange rules, the company is restricted from issuing, selling or transferring treasury shares until 27 September 2026.
Comments